Evidence map›Paper›PMID 26490335›Full record

ArticleBrain : a journal of neurology2016

Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.

Benjamin Pasquereau, Mahlon R DeLong, Robert S Turner

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Parkinsonism disrupts the balance between excitatory and inhibitory activity within the primary motor cortex during movement.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Benjamin Pasquereau1 Department of Neurobiology, Center for Neuroscience and The Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Mahlon R DeLong2 Department of Neurology, Emory University, Atlanta, Georgia, USA.
Robert S Turner1 Department of Neurobiology, Center for Neuroscience and The Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA rturner@pitt.edu.
Center for the Neural Basis of Cognition · USEmory University · US

Funding

Basal ganglia-thalamic signaling in parkinsonism and deep brain stimulationR01NS070865 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TURNER, ROBERT STERLING · 2011 to 2015
$1.8M
Surgery Core - NINDS Institutional Core Grants to Support Neuroscience ResearchP30NS076405 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STRICK, PETER · 2012 to 2016
$1.8M
DBS AND MOTOR CORTICAL FUNCTION IN AN MPTP MODEL OF PDR01NS044551 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TURNER, ROBERT STERLING · 2002 to 2006
$1.6M
NINDS NIH HHS 1P30NS076405-01A1NINDS NIH HHS P30 NS076405NINDS NIH HHS R01 NS044551NINDS NIH HHS R01NS044551NINDS NIH HHS R01 NS070865NINDS NIH HHS R01NS070865
6 · The paper itself

Abstract

Abnormalities in the movement-related activation of the primary motor cortex (M1) are thought to be a major contributor to the motor signs of Parkinson's disease. The existing evidence, however, variably indicates that M1 is under-activated with movement, overactivated (due to a loss of functional specificity) or activated with abnormal timing. In addition, few models consider the possibility that distinct cortical neuron subtypes may be affected differently. Those gaps in knowledge were addressed by studying the extracellular activity of antidromically-identified lamina 5b pyramidal-tract type neurons (n = 153) and intratelencephalic-type corticostriatal neurons (n = 126) in the M1 of two monkeys as they performed a step-tracking arm movement task. We compared movement-related discharge before and after the induction of parkinsonism by administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and quantified the spike rate encoding of specific kinematic parameters of movement using a generalized linear model. The fraction of M1 neurons with movement-related activity declined following MPTP but only marginally. The strength of neuronal encoding of parameters of movement was reduced markedly (mean 29% reduction in the coefficients from the generalized linear model). This relative decoupling of M1 activity from kinematics was attributable to reductions in the coefficients that estimated the spike rate encoding of movement direction (-22%), speed (-40%), acceleration (-49%) and hand position (-33%). After controlling for MPTP-induced changes in motor performance, M1 activity related to movement itself was reduced markedly (mean 36% hypoactivation). This reduced activation was strong in pyramidal tract-type neurons (-50%) but essentially absent in corticostriatal neurons. The timing of M1 activation was also abnormal, with earlier onset times, prolonged response durations, and a 43% reduction in the prevalence of movement-related changes beginning in the 150-ms period that immediately preceded movement. Overall, the results are consistent with proposals that under-activation and abnormal timing of movement-related activity in M1 contribute to parkinsonian motor signs but are not consistent with the idea that a loss of functional specificity plays an important role. Given that pyramidal tract-type neurons form the primary efferent pathway that conveys motor commands to the spinal cord, the dysfunction of movement-related activity in pyramidal tract-type neurons is likely to be a central factor in the pathophysiology of parkinsonian motor signs.

Indexed as

Movement1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAction PotentialsAnimalsCorpus StriatumFemaleMacaca mulattaMotor CortexNeural PathwaysNeuronsParkinsonian DisordersPyramidal Tracts1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineGLMkinematicsloss of specificityMPTPParkinson’s diseaseresponse latency

Identifiers

PMID26490335
PMCPMC4794619
OpenAlexW2149055414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.